Status:
UNKNOWN
Neutrolin Versus Heparin for Locking Hemodialysis Catheters
Lead Sponsor:
King Abdullah International Medical Research Center
Conditions:
Hemodialysis Catheter Infection
Catheter Thrombosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hemodialysis catheter related bacterial infections represent a major cause of mortality and morbidity in the hemodialysis population. Several locking agents had been tried with variable degree of succ...
Eligibility Criteria
Inclusion
- New hemodialysis catheter
- Subject who will need chronic hemodialysis at least twice/week
- Subject likely to require for at least 120 days
- Subject or relative is likely to understand the nature of the study and sign the consent
- Age 18 years and older
Exclusion
- Subject with unstable malignancy
- Subject with liver cirrhosis with encephalopathy
- Subject know to have allergy to heparin, citrate or traoulidine
- Documented history of arterial thrombosis or known to have hypercoagulable state
- Subjects with active skin infections and ulcers
Key Trial Info
Start Date :
April 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 4 2021
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT03425448
Start Date
April 4 2019
End Date
April 4 2021
Last Update
March 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.